Methamphetamine-Induced Neurotoxicity Is Attenuated in Transgenic Mice with a Null Mutation for Interleukin-6

Abstract

Increasing evidence implicates apoptosis as a major mechanism of cell death in methamphetamine (METH) neurotoxicity. The involvement of a neuroimmune component in apoptotic cell death after injury or chemical damage suggests that cytokines may play a role in METH effects. In the present study, we examined if the absence of IL-6 in knockout (IL-6−/−) mice could provide protection against METH-induced neurotoxicity. Administration of METH resulted in a significant reduction of [125I]RTI-121-labeled dopamine transporters in the caudate-putamen (CPu) and cortex as well as depletion of dopamine in the CPu and frontal cortex of wild-type mice. However, these METH-induced effects were significantly attenuated in IL-6−/− animals. METH also caused a decrease in serotonin levels in the CPu and hippocampus of wild-type mice, but no reduction was observed in IL-6−/− animals. Moreover, METH induced decreases in [125I]RTI-55-labeled serotonin transporters in the hippocampal CA3 region and in the substantia nigra-reticulata but increases in serotonin transporters in the CPu and cingulate cortex in wild-type animals, all of which were attenuated in IL-6−/− mice. Additionally, METH caused increased gliosis in the CPu and cortices of wild-type mice as measured by [3H]PK-11195 binding; this gliotic response was almost completely inhibited in IL-6−/− animals. There was also significant protection against METH-induced DNA fragmentation, measured by the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeled (TUNEL) cells in the cortices. The protective effects against METH toxicity observed in the IL-6−/− mice were not caused by differences in temperature elevation or in METH accumulation in wild-type and mutant animals. Therefore, these observations support the proposition that IL-6 may play an important role in the neurotoxicity of METH.

Footnotes

  • Send reprint requests to: Jean Lud Cadet, M.D., Molecular Neuropsychiatry Section, NIH/NIDA Intramural Research program, 5500 Nathan Shock Drive, Baltimore, MD. E-mail:jcadet{at}intra.nida.nih.gov

  • This work was partially supported by National Institutes of Health Grant HD 24605 (T.H.M.).

  • B.L. and I.N.K. have contributed equally to this work.

  • Abbreviations:
    METH
    methamphetamine
    DAT
    dopamine transporters
    DA
    dopamine
    NO
    nitric oxide
    IL-6
    interleukin-6
    CNS
    central nervous system
    IL-6+/+
    wild-type mice
    IL-6−/−
    interleukin-6 knockout mice
    CPu
    caudate-putamen
    NE
    norepinephrine
    DOPAC
    3,4-dihydroxyphenyl acetic acid
    5-HIAA
    5-hydroxyindoleacetic acid
    SERT
    serotonin transporters
    MBBS
    mitochondrial benzodiazepine binding sites
    TUNEL
    terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeled/labeling
    GC
    gas chromatography
    MS
    mass spectrometry
    AMPH
    amphetamine
    IL-1β
    interleukin-1β
    • Received March 13, 2000.
    • Accepted August 30, 2000.
« Previous | Next Article »Table of Contents